A "light" touch on PI3K to interrogate cancer drug resistance.
Overview
Research
Identity
Additional Document Info
Other
View All
Overview
abstract
In this issue of Cell Chemical Biology, Ueda etal. (2022) developed PPAP2 as an improved optogenetic tool to photo-induce PI3K signaling hyperactivation in cancer cells. They demonstrated that enhanced translation of tumor necrosis factor alpha-induced protein 8 (TNFAIP8) might explain PI3K hyperactivation-associated resistance toward DNA damaging anti-cancer alkylating agents.